Chinese investors are investing heavily in US drug start-ups, adding to a flood of cash flowing to groundbreaking health firms. Pictured are US dollar and China yuan notes. Photo illustration: Reuters
Chinese investors are investing heavily in US drug start-ups, adding to a flood of cash flowing to groundbreaking health firms. Pictured are US dollar and China yuan notes. Photo illustration: Reuters

Chinese funds pour US$1.4b into US biotechnology firms in the first three months of the year

It’s unclear whether a deepening trade rift with the US could slow the stream of cash from China to medical innovation hubs such as Silicon Valley and Cambridge, Massachusetts

Chinese investors are investing heavily in US drug start-ups, adding to a flood of cash flowing to groundbreaking health firms. Pictured are US dollar and China yuan notes. Photo illustration: Reuters
Chinese investors are investing heavily in US drug start-ups, adding to a flood of cash flowing to groundbreaking health firms. Pictured are US dollar and China yuan notes. Photo illustration: Reuters
READ FULL ARTICLE